Artificial Intelligence and Machine Learning in the Medical Laboratory: The Future Is Already Here

There is a quiet revolution happening in medical laboratories around the world. Machines are learning to read blood films. Algorithms are detecting cancer cells in tissue sections. Software is predicting sepsis hours before clinicians recognise it clinically. And in some of the most advanced centres, artificial intelligence is interpreting laboratory results and flagging patterns that no human eye could catch in real time.

This is not science fiction. Artificial intelligence (AI) and machine learning (ML) are already embedded in laboratory medicine — in the analysers on the bench, in the middleware that manages results, and in the digital pathology platforms transforming how we examine cells and tissues. For the medical laboratory scientist, this is not a threat but an evolution. Understanding AI is no longer optional — it is becoming a core competency of the profession.

In this post, we take a comprehensive look at what AI and ML actually mean, how they work, where they are being applied in laboratory medicine, what the evidence says, what the limitations are, and what the future holds — particularly for labs in Ghana and West Africa.

1. What Is Artificial Intelligence and Machine Learning?

Artificial intelligence is a broad term for computer systems that perform tasks that would normally require human intelligence — pattern recognition, decision-making, language understanding, and learning from experience. Machine learning is a subset of AI in which systems learn from data to improve their performance without being explicitly programmed for each task.

Within ML, deep learning refers to neural networks with many layers — inspired loosely by the structure of the human brain — that are particularly powerful for analysing images. It is deep learning that has driven the most dramatic AI advances in medicine, including laboratory diagnostics.

How Does a Machine Learning Model Learn?

In supervised learning (the most common approach in medical AI), a model is trained on a large dataset of labelled examples. For instance, a haematology AI might be trained on millions of blood cell images, each labelled by expert haematologists as 'neutrophil', 'lymphocyte', 'blast cell', etc. The model learns the visual features that distinguish each cell type, then applies this learning to new, unseen images.

The quality of the training data is everything. A model trained only on blood films from European populations may perform poorly on films from African patients with different haemoglobin variants or parasite species. This is a critical limitation we will return to.

2. AI in Haematology: The Blood Film Reimagined

2.1 Automated Digital Morphology

The peripheral blood film is one of the most information-rich investigations in laboratory medicine. A skilled morphologist can detect anaemia types, leukaemias, parasites, platelet abnormalities, and dozens of other conditions from a single slide. But expert morphologists take years to train, are scarce in many settings, and human fatigue can affect consistency.

AI-powered digital morphology platforms — most notably the CellaVision DM series (CellaVision DM96, DM1200) and Sysmex DI-60 — use deep learning to automatically capture images of blood cells, pre-classify them into categories (neutrophil, lymphocyte, monocyte, eosinophil, basophil, blast, abnormal forms), and present them to the laboratory scientist for review and validation.

Studies have shown that these systems achieve concordance rates of 90–95% with expert morphologists for normal differentials, with lower but clinically acceptable performance for abnormal cells. Critically, they dramatically reduce the time required for differential counts and standardise reporting across operators — a significant quality improvement.

2.2 Malaria Diagnosis by AI

Malaria diagnosis by microscopy remains the gold standard in resource-limited settings like Ghana, where Plasmodium falciparum is endemic. But microscopic diagnosis is dependent on skilled operators, time-consuming, and prone to fatigue-related errors — particularly in high-volume settings during peak transmission seasons.

AI-based malaria diagnostic tools are under active development and deployment in Africa. The FDA-cleared AI Diagnostics malaria detection system and platforms like Miroculus and Deep Learning-based tools from the Bill and Melinda Gates Foundation's Grand Challenges programmes are demonstrating sensitivity and specificity comparable to expert microscopists. These tools capture smartphone or automated microscopy images of Giemsa-stained films and use convolutional neural networks (CNNs) to detect and count parasitised red cells, calculate parasitaemia, and even species-differentiate.

For a country like Ghana, where malaria accounts for a significant proportion of outpatient laboratory workload, AI-assisted malaria diagnosis could be transformative — enabling faster results, reduced workload, and improved diagnostic accuracy even with less experienced staff.

2.3 AI in Haemoglobin Variant Detection

HPLC-based haemoglobin analysis is already highly automated, but AI is being explored to improve interpretation of complex HPLC traces, particularly in populations like West Africa where multiple variants (HbS, HbC, HbE, HbD, compound heterozygotes) coexist. Pattern recognition algorithms can classify HPLC chromatograms and flag unusual patterns for expert review.

3. AI in Microbiology: From Cultures to Whole-Genome Sequencing

3.1 Automated Colony Reading

Bacterial culture plates require reading after 18–24 hours of incubation — a labour-intensive process requiring trained eyes. AI-powered plate reading systems (e.g., Copan WASPLab, BD Kiestra InoquIA) use machine vision to photograph plates at multiple timepoints, detect and count colonies, assess haemolysis patterns, and flag significant growth — reducing hands-on time and enabling 24/7 processing without human intervention overnight.

These systems also improve turnaround time — a critical factor in sepsis management, where delayed blood culture results are directly linked to mortality.

3.2 AI-Assisted Antimicrobial Susceptibility Testing (AST)

Automated AST systems (VITEK 2, BD Phoenix, MicroScan) already use sophisticated algorithms to calculate MICs and interpret susceptibility from growth kinetics. AI is extending this by predicting resistance genotypes from phenotypic data, flagging unusual resistance patterns that may indicate novel mechanisms, and integrating AST results with patient clinical data and local resistance epidemiology to suggest optimal antibiotic regimens.

3.3 Whole-Genome Sequencing (WGS) and Bioinformatics

WGS is increasingly used for outbreak investigation, AMR gene detection, and pathogen characterisation. The data generated by WGS is enormous — millions of base pairs per sample — and AI/ML algorithms are essential for analysing it. Bioinformatics pipelines powered by ML can identify resistance genes, predict minimum inhibitory concentrations from genome sequences, construct phylogenetic trees for outbreak tracing, and even predict clinical outcomes from pathogen genotype.

In West Africa, WGS capacity is growing — institutions like the Noguchi Memorial Institute for Medical Research (NMIMR) in Ghana and the West African Centre for Cell Biology of Infectious Pathogens (WACCBIP) at the University of Ghana are developing bioinformatics capacity that will bring these tools to the region.

4. AI in Clinical Chemistry: Smarter Analysers and Smarter Interpretation

4.1 Delta Checks and Autoverification

Modern laboratory information systems (LIS) use rule-based algorithms to automatically verify results that fall within expected ranges and flag those that do not — a process called autoverification. AI is enhancing this by moving beyond simple rules to predictive models that consider the patient's history, diagnosis, medication, and trending results to decide whether an individual result is plausible or requires review.

Delta checks — comparisons of current results against previous results for the same patient — are a classic quality control tool. AI-enhanced delta checks can learn patient-specific biological variation patterns and apply more intelligent thresholds than fixed percentage changes.

4.2 Sepsis Prediction Algorithms

Sepsis kills approximately 11 million people per year globally. Early recognition is the single most important determinant of survival. AI algorithms — including those embedded in electronic health records (EHR) systems like Epic's Sepsis Prediction Model and the widely studied InSight sepsis algorithm — analyse laboratory results (WBC, lactate, creatinine, bilirubin, platelet trends), vital signs, and clinical data in real time to generate sepsis risk scores, alerting clinicians to deteriorating patients hours before the clinical picture is obvious.

In Ghana and West Africa, where EHR penetration is growing, these kinds of predictive tools integrated with laboratory middleware represent a realistic near-future deployment that could significantly impact sepsis mortality.

4.3 Reflex Testing Automation

AI can intelligently trigger reflex tests — additional tests ordered automatically based on a primary result — applying clinical decision support rules that reflect current guidelines. For example, a low TSH could automatically trigger free T4 testing; a positive HIV screen could trigger confirmatory testing. This reduces clinician cognitive load and ensures no critical follow-up is missed.

5. AI in Histopathology and Cytology: Digital Pathology

Digital pathology — the scanning of glass slides to produce high-resolution digital images — combined with AI image analysis is arguably the most advanced and transformative application of AI in laboratory medicine.

5.1 Cancer Detection and Grading

Deep learning algorithms have demonstrated remarkable performance in detecting and grading cancers from histological images. Published studies have shown AI systems matching or exceeding pathologist performance for: prostate cancer Gleason grading, breast cancer detection and HER2 scoring, lung cancer subtype classification, colorectal cancer polyp classification, cervical cytology (Pap smear) screening, and detection of lymph node metastases.

The FDA and CE have cleared several AI pathology tools. Companies including Paige AI, PathAI, Ibex Medical Analytics, and Roche's Navify platform are deploying clinical-grade AI pathology solutions globally. Some of these systems are being piloted in African teaching hospitals.

5.2 AI in Cervical Cancer Screening

Cervical cancer is the fourth most common cancer in women worldwide and disproportionately affects sub-Saharan Africa, where screening coverage is low and pathologist numbers are insufficient. AI-based cervical cytology screening — using smartphone-connected colposcopes and automated Pap smear analysis — is being piloted in several African countries as a solution to the screening capacity gap. These tools can screen slides with high sensitivity for CIN2+ lesions, flagging positive cases for review by the limited number of available cytologists.

6. AI in Blood Banking and Transfusion Medicine

AI applications in blood banking include: predictive models for blood demand forecasting (reducing wastage from expiry), automated crossmatch and compatibility checking, machine learning models to predict transfusion requirements in surgical patients, and AI tools to detect labelling errors and patient identification mismatches in the transfusion chain — addressing one of the most common causes of serious transfusion reactions.

7. Limitations and Challenges of AI in Laboratory Medicine

For all its promise, AI in laboratory medicine faces significant challenges that must be acknowledged honestly:

7.1 Data Bias and Generalisability

Most AI models have been trained predominantly on data from North America, Europe, and East Asia. Performance can degrade significantly when deployed in populations that were underrepresented in training data — different disease prevalences, different haemoglobin variants, different parasite species, different nutritional deficiencies. AI tools validated for Western populations cannot simply be imported to West Africa without local validation studies.

7.2 Black Box Problem

Many deep learning models are opaque — they produce outputs without explaining how they arrived at them. In laboratory medicine, where results are acted upon clinically, this lack of explainability is a significant barrier to trust and adoption. Explainable AI (XAI) techniques are an active area of research.

7.3 Infrastructure Requirements

AI tools require reliable electricity, internet connectivity, robust computing hardware, and digital laboratory infrastructure (LIS, digital pathology scanners, digital analysers). These requirements present significant barriers in lower-resource settings in West Africa, though mobile-first AI tools designed for low-bandwidth environments are emerging.

7.4 Regulatory and Ethical Frameworks

AI medical devices require regulatory approval (FDA, CE, or national equivalents). In Ghana and many African countries, regulatory frameworks for AI diagnostics are still developing. Data privacy, ownership of AI-generated diagnostic data, liability for AI errors, and the potential displacement of laboratory workers are critical ethical and legal questions that are still being worked out globally.

7.5 The Human-AI Partnership

AI is a tool, not a replacement for the medical laboratory scientist. AI systems make errors — sometimes spectacularly. The role of the laboratory scientist evolves but does not disappear: validating AI outputs, recognising AI failure modes, maintaining quality systems, and providing the clinical context and judgment that no algorithm currently possesses are irreplaceable human contributions.

8. AI in MLS Education and Training

AI is also transforming how medical laboratory scientists are trained. AI-powered virtual microscopy platforms allow students to practice blood film reading, histology, and parasitology on digital images — with immediate AI-assisted feedback. Large language models (like the one powering LabLens!) can generate personalised study materials, explain complex concepts, and create practice questions on demand. Simulation platforms using AI can train laboratory scientists in quality control decision-making, critical value recognition, and troubleshooting without the risk of real patient consequences.

9. What This Means for MLS Professionals in Ghana and West Africa

For medical laboratory scientists in Ghana and West Africa, AI represents both opportunity and challenge:

• Opportunity to leapfrog infrastructure gaps — mobile-first AI tools can bring advanced diagnostics to rural settings without requiring the full infrastructure of a reference laboratory.

• Opportunity to enhance accuracy and throughput in high-burden settings like malaria diagnosis, TB detection (AI-powered GeneXpert interpretation, digital X-ray AI for TB), and cervical cytology screening.

• Challenge to develop local AI expertise — Africa needs medical laboratory scientists who understand AI, can participate in local validation studies, and can advocate for locally appropriate AI tools rather than simply accepting products designed for other contexts.

• Challenge to ensure AI amplifies human expertise rather than replacing it — particularly in settings where laboratory scientists are already scarce.

• Opportunity in training — MLS programmes in Ghana are beginning to integrate informatics and digital health into their curricula. Students who embrace this will be at the forefront of the profession's evolution.

Conclusion

Artificial intelligence is not the future of laboratory medicine — it is the present. From the CellaVision terminal that pre-classifies your blood film differential to the VITEK algorithm that interprets your AST results, AI is already woven into the daily work of the clinical laboratory. The question for today's medical laboratory scientist is not whether to engage with AI, but how to engage with it intelligently — understanding what it can and cannot do, validating it rigorously for local contexts, and harnessing it to deliver better, faster, more equitable diagnostics for every patient.

The laboratory of the future will be built by scientists who combine deep domain expertise with digital fluency. That future starts now. And it starts with you.